Skip to main content
. 2012 Jul 25;303(7):F918–F927. doi: 10.1152/ajprenal.00678.2011

Fig. 5.

Fig. 5.

RNA silencing of CK1δ/ε reduces basal αENaC and Fxyd5 expression. A: mpkCCDc14 cells were treated with nontarget or CK1δ and ε siRNA for 48 h. Real-time PCR was used to evaluate changes in CK1δ (A), CK1ε (B), αENaC (C), or Fxyd5 (D) gene expression in CK1δ/ε siRNA-treated cells vs. nontarget. *P < 0.05, **P < 0.01; n = 6–8. Values are represented as means ± SE.